Substance Use Disorder Webinar Series: Bonus Question-and-Answer Session (On-Demand)

Substance Use Disorder Webinar Series: Bonus Question-and-Answer Session (On-Demand)

Presenters: Ellen F. Eaton, MD, Sandra A. Springer, MD

Release date: February 6, 2024
Not available for CME credit


Assessment of Needs

The 6-part IAS–USA webinar series on substance use disorder (SUD), designed by expert faculty Sandra A. Springer, MD, and Ellen F. Eaton, MD, has been a resounding success, with the first 5 webinars now available on-demand and webinar 6 open for registration (see below for more information). Due to the overwhelming interest in this topic by attendees and the discussion points we were unable to address within the scope of these presentations, our course directors are pleased to offer a bonus Q and A session. Please note that CME is not offered for this webinar.


Who Should Attend

This webinar is designed for clinical decision makers who are actively involved in HIV care and research, including physicians, physician assistants, nursing professionals, pharmacists, and other health care professionals.

About the IAS–USA SUD Webinar Series

The Drug Enforcement Administration (DEA) now requires that all DEA certificate holders complete continuing education comprising 8 hours of training specific to the management of SUD in order to obtain DEA registration.

The IAS–USA is excited to support clinicians in meeting these new requirements with a free, 6-part webinar series comprising 8 hours of training to help you provide the best possible care for your patients! Consistent with the IAS–USA mission, the series includes specific guidance on SUDs in people with HIV, on topics ranging from the etiology and screening of SUDs to the management of specific SUDs, such as opioid, stimulant, tobacco, and alcohol use disorders.

To access the 6  webinars, now available on-demand, visit

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.  

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” 

IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.


Dr Springer reported receiving consulting fees from Alkermes, Inc, and receiving in-kind study drug donations from Alkermes, Inc, and Indivior, Inc. (Updated October 25, 2023)

Dr Eaton reported receiving consulting fees from Gilead Sciences. (Updated November 20, 2023)


Planner/Reviewer 1 reported no relevant financial relationships with ineligible companies. (Updated December 6, 2023)

Planner/Reviewer 2 reported no relevant financial relationships with ineligible companies. (Updated December 6, 2023)

COW Board

The financial relationships of the COW Board can be found here: 

CME Credits

This activity does not offer CME credit.

Grant Support

The activity is sponsored and funded by the IAS–USA. IAS–USA is a mission-based, nonmembership, 501(c)(3) not-for profit organization. No private sector or government funding was used to support the effort.


Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at or 415-544-9400.

Course Materials

How Watch and Evaluate

  1. Start the Activity by clicking "START COURSE" located above.
    Please note that the "START COURSE" will no longer be visible once you clicked it once.
  2. Watch the webinar here.
  3. Return to this page and follow this link to the evaluation form.